ORIGINAL RESEARCH
Published on 14 Aug 2026
Thrombotic complications in patients treated with immune checkpoint inhibitors: a retrospective study of incidence, risk factors, and survival outcomes
doi 10.3389/fimmu.2026.1852772
- 300 views
- Frontiers in Cardiovascular Medicine
- Cardio-Oncology
- Research Topics
- Novel Insights in Cardiovascular toxicity induced by New Anticancer Treatments
Novel Insights in Cardiovascular toxicity induced by New Anticancer Treatments
4,289
Total downloads
29k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
CASE REPORT
Published on 11 Aug 2026
Case Report: Immune checkpoint inhibitor-induced myositis/myocarditis with myasthenia gravis-like symptoms in a colon cancer patient with suspected thymic metastasis
doi 10.3389/fonc.2026.1808170
- 246 views
ORIGINAL RESEARCH
Published on 08 Jul 2026
Sex-based disparities in cardiovascular outcomes: real-world evidence following chimeric antigen receptor T-cell therapy
doi 10.3389/fcvm.2026.1838296
- 680 views
ORIGINAL RESEARCH
Published on 06 Jul 2026
Innominate artery versus combined innominate and femoral artery perfusion in acute type A aortic dissection: a comparison of surgical efficiency and early outcomes
doi 10.3389/fcvm.2026.1808621
- 614 views
ORIGINAL RESEARCH
Published on 02 Jul 2026
Immune and stromal remodeling underlies radiation-induced heart injury: insights from single-cell transcriptomics
doi 10.3389/fcvm.2026.1836858
- 983 views
ORIGINAL RESEARCH
Published on 01 Jul 2026
Roles of myeloperoxidase and the AMPK/PI3K/AKT/eNOS pathway in osimertinib-induced cardiotoxicity: multilevel evidence from disequilibrium analysis, network pharmacology, mendelian randomization, and animal experiments
doi 10.3389/fphar.2026.1776465
- 1,650 views
ORIGINAL RESEARCH
Published on 01 Jul 2026
Cardiovascular toxicity of CDK4/6 inhibitors combined with endocrine therapy versus endocrine therapy alone in HR+/HER2- breast cancer: a real-world study based on the FAERS database
doi 10.3389/fphar.2026.1831639
- 958 views
ORIGINAL RESEARCH
Published on 26 Jun 2026
Red cell distribution width: a novel and accessible predictor for immune checkpoint inhibitor-associated myocarditis—a retrospective cohort study
doi 10.3389/fcvm.2026.1737093
- 968 views
CASE REPORT
Published on 19 Jun 2026
Case Report: Adebrelimab-associated suspected immune-related myocarditis with myositis/myasthenia gravis overlap syndrome (IM3OS): A rapidly fatal case and clinical implications
doi 10.3389/fonc.2026.1778682
- 1,075 views
- 1 citation
ORIGINAL RESEARCH
Published on 09 Jun 2026
SIMVASTATIN as a potential protective strategy against doxorubicin-induced cardiotoxicity
doi 10.3389/fcvm.2026.1846253
- 1,781 views
ORIGINAL RESEARCH
Published on 28 May 2026
Short-term cardiotoxicity and early echocardiographic changes following autologous hematopoietic stem cell transplantation: a single-center retrospective analysis
doi 10.3389/fcvm.2026.1809002
- 1,329 views
ORIGINAL RESEARCH
Published on 19 May 2026
Comparative dosimetric and radiobiological assessment of a hybrid-VMAT strategy incorporating supplemental short-arcs for left-sided postmastectomy radiotherapy
doi 10.3389/fonc.2026.1825312
- 1,439 views
Published in
Frontiers in Cardiovascular Medicine
Cardio-Oncology
Other participating journals
Frontiers in Medicine
- 3.6 impact factor
- 5.4 citescore
Frontiers in Oncology
Cardio-Oncology
- 3.4 impact factor
- 6.6 citescore
Frontiers in Pharmacology
- 5.4 impact factor
- 9.5 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: